GSK delivers continued strong performance and upgrades 2024 guidance - GSK
- GSK delivers continued strong performance and upgrades 2024 guidance GSK
- GSK raises outlook despite warning on vaccine sales Financial Times
- GSK forecast upgrade fails to impress the market Proactive Investors UK
- Drugs firm GSK raises targets after strong cancer and HIV treatment sales Yahoo Finance UK
- GSK boosts profit forecast after strong sales in cancer and HIV treatments The Mirror